Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review

  • ID: 4285095
  • SWOT Analysis
  • 52 pages
  • GlobalData
  • Aptevo Therapeutics Inc
1 of 5

FEATURED COMPANIES

  • Amgen Inc
  • Biogen Inc
  • Bioverativ Inc
  • MORE
Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and children with hemophilia B. Its pipeline includes immune-oncology candidates for the treatment metastatic castration-resistant prostate cancer, peripheral T-cell lymphoma (PTCL), hematological malignancies, psoriasis and inflammatory bowel disease, and solid tumors. Aptevo is also developing a lead bispecific antibody candidate in collaboration with Alligator Bioscience AB for the treatment of various types of cancer. The company’s immuno-oncology candidates are built on its proprietary Adaptir platform. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D
Aug 09, 2018: Aptevo Therapeutics reports second quarter 2018 financial results
May 10, 2018: Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Mar 13, 2018: Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
Nov 09, 2017: Aptevo Therapeutics Reports Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amgen Inc
  • Biogen Inc
  • Bioverativ Inc
  • MORE
Section 1 - About the Company

Aptevo Therapeutics Inc - Key Facts
Aptevo Therapeutics Inc - Key Employees
Aptevo Therapeutics Inc - Key Employee Biographies
Aptevo Therapeutics Inc - Major Products and Services
Aptevo Therapeutics Inc - History
Aptevo Therapeutics Inc - Company Statement
Aptevo Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview
Aptevo Therapeutics Inc - Business Description
R&D Overview
Aptevo Therapeutics Inc - Corporate Strategy
Aptevo Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Aptevo Therapeutics Inc - Strengths
Aptevo Therapeutics Inc - Weaknesses
Aptevo Therapeutics Inc - Opportunities
Aptevo Therapeutics Inc - Threats
Aptevo Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Aptevo Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D
Aug 09, 2018: Aptevo Therapeutics reports second quarter 2018 financial results
May 10, 2018: Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Mar 13, 2018: Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
Nov 09, 2017: Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
Oct 02, 2017: Aptevo Therapeutics Presents New Data on Enhanced Features of Its Next Generation ADAPTIR Bispecific Platform at the World Bispecific Summit
Aug 29, 2017: ImmunoPrecise announces R&D success using the OmniAb® platform to develop fully human antibodies
Aug 10, 2017: Aptevo Therapeutics Reports Second Quarter 2017 Financial Results
May 12, 2017: Aptevo Therapeutics Reports First Quarter 2017 Financial Results
May 05, 2017: Aptevo Therapeutics Presents Detailed Overview of its Adaptir Protein Therapeutic Platform at the 13th Annual Pegs Summit

Section 6 – Appendix

Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Aptevo Therapeutics Inc, Key Facts
Aptevo Therapeutics Inc, Key Employees
Aptevo Therapeutics Inc, Key Employee Biographies
Aptevo Therapeutics Inc, Major Products and Services
Aptevo Therapeutics Inc, History
Aptevo Therapeutics Inc, Other Locations
Aptevo Therapeutics Inc, Subsidiaries
Aptevo Therapeutics Inc, Key Competitors
Aptevo Therapeutics Inc, Ratios based on current share price
Aptevo Therapeutics Inc, Annual Ratios
Aptevo Therapeutics Inc, Annual Ratios (Cont...1)
Aptevo Therapeutics Inc, Interim Ratios
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD
Aptevo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Aptevo Therapeutics Inc, Performance Chart (2013 - 2017)
Aptevo Therapeutics Inc, Ratio Charts
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Bioverativ Inc
  • Amgen Inc
  • Biogen Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll